Weekly docetaxel (D) and irinotecan (I) in patients (pts) with recurrent or metastatic head and neck cancer (HNC): A phase II trial of the Eastern Cooperative Oncology Group (ECOG)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 5528-5528 ◽  
Author(s):  
A. Argiris ◽  
M. A. Goldwasser ◽  
B. Brockstein ◽  
R. Axelrod ◽  
A. Forastiere
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Trial ◽  
Eastern Cooperative Oncology Group ◽  
Oncology Group ◽  
Weekly Docetaxel

scholarly journals Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)

2018 ◽  
Vol 49 (1) ◽  
pp. 37-41 ◽  
Author(s):  
Takashi Matsuzuka ◽  
Naomi Kiyota ◽  
Junki Mizusawa ◽  
Tetsuo Akimoto ◽  
Masato Fujii ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Clinical Impact ◽  
Advanced Head

scholarly journals Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer

1991 ◽  
Vol 2 (2) ◽  
pp. 151-152 ◽  
Author(s):  
J.M. Buesa ◽  
E. Esteban ◽  
E. Estrad ◽  
F.J. Barón ◽  
I. Palacio ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Trial

scholarly journals Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1281-1288 ◽  
Author(s):  
Missak Haigentz ◽  
Mimi Kim ◽  
Catherine Sarta ◽  
Juan Lin ◽  
Roger S. Keresztes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Neck Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Deacetylase Inhibitor

scholarly journals Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group

1999 ◽  
Vol 10 (4) ◽  
pp. 475-478 ◽  
Author(s):  
G. Fountzilas ◽  
G. Stathopoulos ◽  
C. Nicolaides ◽  
A. Kalogera-Fountzila ◽  
H. Kalofonos ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Study ◽  
Oncology Group

Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial

Oral Oncology ◽  
2018 ◽  
Vol 82 ◽  
pp. 144-151 ◽  
Author(s):  
Marco Siano ◽  
Vittoria Espeli ◽  
Nicolas Mach ◽  
Paolo Bossi ◽  
Lisa Licitra ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Phase Ii ◽  
Neck Cancer ◽  
Phase Ii Trial ◽  
Gene Signatures
Sign in / Sign up

Export Citation Format

Share Document